Updated: 22 December 2021
Philip Morris International (PMI) has dedicated significant resources to the development and scientific assessment of Reduced Risk Products (RRPs) with the ambition of providing adult smokers who would otherwise continue to smoke with less harmful alternatives to cigarettes.
Our research program is inspired by the practices of the pharmaceutical industry and includes research on product development, methods to substantiate risk reduction and ways to assess the impact on population harm. We believe it is important to share our data to facilitate and encourage independent verification of methodologies and findings.
PMI accepts proposals under an Investigator Initiated Studies (IIS) pilot program, to support external scientists to advance and verify RRP science. Check the list of supported studies.
Those interested in submitting a proposal to the program should first read the guidelines and the terms and conditions of the program. Then they can download the IIS concept proposal submission template for the first step of the application process, and email their submissions to firstname.lastname@example.org.